EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma

Suparauk Geanphun, Pranya Sakiyalak

Siriraj Medical Journal · 01.10.2026 · 71 (6) · 472-479

DOI: 10.33192/smj.2019.70 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Siriraj Medical Journal, online erschienen am 01.10.2026. Verfasst von Suparauk Geanphun und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A corrigendum has been published for this article. Please see the corrigendum here: https://doi.org/10.33192/smj.v78i10.285017 Objective: Thymic carcinoma is a rare malignancy that has a poor prognosis and low 5-year survival. The rarity of this disease and the variety of histologic subtypes has limited the evidence needed to establish disease-specific staging and treatment guidelines. The aim of this study was to investigate overall survival, the factors that predict survival, and the treatment modalities that influence survival in patients with thymic carcinoma.

Methods

All thymic carcinoma cases diagnosed and treated at Siriraj Hospital (Bangkok, Thailand) during 1997-2013 were retrospectively reviewed. Univariate and multivariate analyses were performed to identify factors that predict survival, and overall survival was estimated by Kaplan-Meier method.

Results

Of the 45 patients diagnosed during the study period, 8 were lost to follow-up. The remaining 37 patients were included in our analysis. The median survival time was 2.5 years, with 5-year and 10-year survival of 40% and 16%, respectively. In univariate analysis, tumors >10 cm (p=0.017), high-grade histologic subtypes (p=0.014), and high Masaoka stage (p=0.011) were significant determinants of survival. Multivariate analysis revealed tumor size (HR: 3.594, 95% CI: 1.103-11.714; p=0.034) and high-grade histologic subtypes (HR: 8.175, 95% CI: 1.689-39.566; p=0.009) to be independent predictors of survival. Patients who underwent tumor removal had significantly longer median survival time than those who didn’t (3.85 vs. 0.63 years; p=0.005).

Conclusion

Thymic carcinoma patients have low 5-year and 10-year survival. Tumor size and high-grade histologic subtype were identified as independent predictors of survival, and surgical therapy was found to be significantly associated with longer median survival time.

Zitieren

APA

Geanphun, S., & Sakiyalak, P. (2026). Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma. Siriraj Medical Journal, 71(6), 472-479. https://doi.org/10.33192/smj.2019.70

Vancouver

Geanphun S, Sakiyalak P. Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma. Siriraj Medical Journal. 2026;71(6):472-479. doi:10.33192/smj.2019.70

BibTeX
@article{Geanphun2026,
  author = {Geanphun, Suparauk and Sakiyalak, Pranya},
  title = {Survival and Factors Predictive of Survival in Patients with Thymic Carcinoma},
  journal = {Siriraj Medical Journal},
  year = {2026},
  volume = {71},
  number = {6},
  pages = {472--479},
  doi = {10.33192/smj.2019.70}
}
Kostenlos starten →